Ole Andreas Halvorsen
Viking Global Investors
Viking Global Investors 13F holdings
Ole Andreas Halvorsen's Portfolio
- Portfolio value:
- $22.91B~
- # of securities:
- 62 (+2)
- Reported for:
- 30 Jun 2014 (Q2)
- Latest filing date:
- 14 Aug 2014
What stocks did Ole Andreas Halvorsen own in 2014 Q2?
What was Ole Andreas Halvorsen's 2014 Q2 portfolio?
Viking Global Investors has disclosed a total of 62 security holdings in their (2014 Q2) SEC 13F filing(s) with portfolio value of $22,906,066,000.
Viking Global Investors's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Ole Andreas Halvorsen's original 13F reports (2014 Q2) are the official SEC institutional disclosure documents covering all reported equity positions.
62 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Walgreens Boots Alliance Inc
|
6.52%
|
$74.13
|
|
2013 Q4
|
~0.75 years
|
-16.46% (-3.97M)
|
||||
|
|
Valeant Pharmaceuticals International Inc
|
6.51%
|
$126.12
|
|
2013 Q2*
|
> 1 years
|
+27.27% (+2.53M)
|
||||
|
|
Illumina Inc
|
6.23%
|
$178.54
|
+22.59%($218.88)
|
2013 Q4
|
~0.75 years
|
-9.85% (-873.4K)
|
||||
|
|
Lowe's Companies Inc
|
4.80%
|
$47.99
|
+349.30%($215.62)
|
2013 Q3
|
~1.00 year
|
+26.48% (+4.8M)
|
||||
|
|
LyondellBasell Industries NV
|
4.59%
|
$97.65
|
-33.29%($65.14)
|
2013 Q2*
|
> 1 years
|
-16.23% (-2.09M)
|
||||
|
|
Thermo Fisher Scientific Inc
|
4.26%
|
$118.00
|
+429.50%($624.82)
|
2013 Q2*
|
> 1 years
|
-14.45% (-1.4M)
|
||||
|
|
Pioneer Natural Resources Co
|
4.09%
|
$229.81
|
|
2014 Q1
|
~0.50 years
|
+148.72% (+2.44M)
|
||||
|
|
Baidu Inc
|
3.82%
|
$186.81
|
-50.68%($92.14)
|
2013 Q3
|
~1.00 year
|
+10.44% (+442.47K)
|
||||
|
|
Capital One Financial Corp
|
3.67%
|
$82.60
|
+162.24%($216.61)
|
2013 Q2*
|
> 1 years
|
-6.74% (-734.63K)
|
||||
|
|
Regeneron Pharmaceuticals Inc
|
3.65%
|
$282.47
|
+193.35%($828.62)
|
2014 Q1
|
~0.50 years
|
+181.75% (+1.91M)
|
||||
Completely sold out
18 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
American International Group Inc
|
2013 Q4
|
~0.50 years
|
|||
|
|
Verizon Communications Inc
|
2013 Q4
|
~0.50 years
|
|||
|
|
Bank of America Corp
|
2013 Q3
|
~0.75 years
|
|||
|
|
U.S. Bancorp
|
2014 Q1
|
~0.25 years
|
|||
|
|
ST JUDE MEDICAL INC
|
2013 Q4
|
~0.50 years
|
|||
|
|
Booking Holdings Inc
|
2014 Q1
|
~0.25 years
|
|||
|
|
Biogen Inc
|
2014 Q1
|
~0.25 years
|
|||
|
|
Altaba Inc
|
2014 Q1
|
~0.25 years
|
|||
|
|
MYLAN INC
|
2014 Q1
|
~0.25 years
|
|||
|
|
Voya Financial Inc
|
2014 Q1
|
~0.25 years
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".
* % of portfolio: the total can exceed 100%, e.g. when there are also options positions, which can be short.